News & Events

• November 28, 2018
  

  Sharing Data to Accelerate Medicines Development and Improve Neonatal Care: Data Standards and Harmonized Definitions

  Kate Costeloe, MD, Mark A. Turner, MBChB, PhD, Michael A. Padula, MD, MBI, Prakesh S. Shah, MD, Neena Modi, MD, Roger Soll, MD, Dominique Haumont, MD, Satoshi Kusuda, MD, Wolfgang Göpel, MD, Yun Sil Chang, MD, PhD, P. Brian Smith, MD, Kei Lui, MD, Jonathan M. Davis, MD, and Lynn D. Hudson, PhD, and the International Neonatal Consortium

• November 13, 2018
  

  Critical Path for Alzheimer’s Disease 2018 Annual Meeting and Regulatory Science Workshop

  November 13, 2018 Overview and Objectives: The Critical Path for Alzheimer’s Disease (CPAD) is a public-private partnership aimed at creating new tools and methods that can be applied to increase the efficiency of the development process leading to treatments for neurodegenerative diseases that progress to dementia with the shared characteristics of Alzheimer disease (AD), the...
• November 10, 2018
  

  Comparability of a Provisioned Device Versus Bring Your Own Device for Completion of Patient-Reported Outcome (PRO) Measures by Participants with Chronic Obstructive Pulmonary Disease (COPD): Quantitative Interview Findings

• November 10, 2018
  

  Comparability of a Provisioned Device Versus Bring Your Own Device for Completion of Patient-Reported Outcome (PRO) Measures by Participants with Chronic Obstructive Pulmonary Disease (COPD): Qualitative Interview Findings

• November 8, 2018
  

  Profiles in Business with Tucson Metro Chamber

  C-Path President and CEO Martha Brumfield, Ph.D., talks about today’s drug discovery process, C-Path’s global impact and what’s next for the organization on the Tucson Metro Chamber’s Profiles in Business podcast.

  Listen Now.